Bayer Cropscience Limited
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more
Bayer Cropscience Limited (BAYERCROP) - Total Liabilities
Latest total liabilities as of September 2025: ₹20.68 Billion INR
Based on the latest financial reports, Bayer Cropscience Limited (BAYERCROP) has total liabilities worth ₹20.68 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bayer Cropscience Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Bayer Cropscience Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bayer Cropscience Limited Competitors by Total Liabilities
The table below lists competitors of Bayer Cropscience Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kunshan Kersen Science & Tech
SHG:603626
|
China | CN¥3.18 Billion |
|
Redde Northgate PLC
F:21W
|
Germany | €1.42 Billion |
|
COFCO Capital Holdings Co Ltd
SHE:002423
|
China | CN¥140.48 Billion |
|
Semitronix Corp. A
SHE:301095
|
China | CN¥215.46 Million |
|
Faw Car Co Ltd
SHE:000800
|
China | CN¥49.46 Billion |
|
MFA Financial Inc
NYSE:MFA
|
USA | $10.28 Billion |
|
Teladoc Inc
NYSE:TDOC
|
USA | $1.49 Billion |
|
T1 Energy Inc.
NYSE:TE
|
USA | $1.24 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Bayer Cropscience Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.34 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bayer Cropscience Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bayer Cropscience Limited (2004–2025)
The table below shows the annual total liabilities of Bayer Cropscience Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹23.95 Billion | +37.07% |
| 2024-03-31 | ₹17.48 Billion | -11.13% |
| 2023-03-31 | ₹19.66 Billion | +7.54% |
| 2022-03-31 | ₹18.29 Billion | +8.27% |
| 2021-03-31 | ₹16.89 Billion | +33.71% |
| 2020-03-31 | ₹12.63 Billion | +24.07% |
| 2019-03-31 | ₹10.18 Billion | +34.58% |
| 2018-03-31 | ₹7.57 Billion | -1.59% |
| 2017-03-31 | ₹7.69 Billion | +12.65% |
| 2016-03-31 | ₹6.82 Billion | -7.87% |
| 2015-03-31 | ₹7.41 Billion | +14.91% |
| 2014-03-31 | ₹6.45 Billion | +33.26% |
| 2013-03-31 | ₹4.84 Billion | -53.85% |
| 2012-03-31 | ₹10.48 Billion | +16.28% |
| 2011-03-31 | ₹9.01 Billion | +72.20% |
| 2010-03-31 | ₹5.23 Billion | +7.63% |
| 2009-03-31 | ₹4.86 Billion | +0.24% |
| 2008-03-31 | ₹4.85 Billion | +47.95% |
| 2007-03-31 | ₹3.28 Billion | +0.04% |
| 2006-03-31 | ₹3.28 Billion | +3.69% |
| 2005-03-31 | ₹3.16 Billion | -33.76% |
| 2004-03-31 | ₹4.77 Billion | -- |